Mo. firm expected to benefit from Obama policy, stimulus plan

03/12/2009 | St. Louis Post-Dispatch

St. Louis-based Sigma-Aldrich, a provider of scientific kits and products for stem cell research, is one of the firms expected to benefit from the recent lifting of federal funding limits on embryonic stem cell research. The company also is looking to get a boost from the stimulus plan that allotted NIH funding for induced pluripotent stem cell research.

View Full Article in:

St. Louis Post-Dispatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX